Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solriamfetol in Binge Eating Disorder

NCT04602936 is registered in ClinicalTrials.gov with Lindner Center of HOPE as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solriamfetol in Binge Eating Disorder
Lead sponsor
Lindner Center of HOPE
Phase
Phase 4
Overall status
Unknown status
Start date
June 15, 2021
Completion date
December 30, 2024
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder